JPC0323

JPC0323 is a dual positive allosteric modulator targeting the 5-HT2C and 5-HT2A receptors, exhibiting favorable pharmacokinetics and brain bioavailability. It is a research tool used in preclinical studies, including in vitro binding assays and in vivo models, to investigate neurological disorders such as schizophrenia and addiction.